Eyewire News: The Podcast

Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

4 min · 27. maj 2026
Billede af episoden Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

Description

Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images. Learn more about your ad choices. Visit megaphone.fm/adchoices [https://megaphone.fm/adchoices]

Comments

0

Be the first to comment

Sign up now and become a member of the Eyewire News: The Podcast community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

101 episodes